Vaughan David Investments’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$17.9M Sell
49,416
-1,250
-2% -$428K 0.36% 89
2026
Q1
$17.8M Sell
50,666
-2,198
-4% -$784K 0.38% 88
2025
Q4
$17.3M Sell
52,864
-112,013
-68% -$35.5M 0.38% 87
2025
Q3
$46.5M Sell
164,877
-1,704
-1% -$494K 1% 47
2025
Q2
$46.5M Sell
166,581
-211
-0.1% -$59.8K 1.04% 44
2025
Q1
$52M Sell
166,792
-9,496
-5% -$2.8M 1.22% 27
2024
Q4
$45.9M Buy
176,288
+608
+0.3% +$180K 1.09% 37
2024
Q3
$56.6M Buy
175,680
+70
+0% +$22.9K 1.3% 15
2024
Q2
$54.9M Buy
175,610
+450
+0.3% +$132K 1.39% 14
2024
Q1
$49.8M Sell
175,160
-245
-0.1% -$71.7K 1.24% 21
2023
Q4
$50.5M Buy
175,405
+62
+0% +$16.9K 1.38% 14
2023
Q3
$47.1M Buy
175,343
+1,317
+0.8% +$329K 1.43% 13
2023
Q2
$38.6M Buy
174,026
+898
+0.5% +$208K 1.13% 30
2023
Q1
$41.9M Sell
173,128
-629
-0.4% -$154K 1.27% 22
2022
Q4
$45.6M Sell
173,757
-1,346
-0.8% -$361K 1.36% 16
2022
Q3
$39.5M Buy
175,103
+915
+0.5% +$222K 1.32% 14
2022
Q2
$42.4M Buy
174,188
+750
+0.4% +$184K 1.35% 14
2022
Q1
$41.9M Buy
173,438
+1,447
+0.8% +$332K 1.24% 23
2021
Q4
$38.7M Buy
171,991
+1,022
+0.6% +$216K 1.13% 32
2021
Q3
$36.4M Sell
170,969
-250
-0.1% -$57.5K 1.16% 29
2021
Q2
$41.7M Buy
171,219
+1,981
+1% +$487K 1.3% 21
2021
Q1
$42.1M Sell
169,238
-828
-0.5% -$198K 1.33% 19
2020
Q4
$39.1M Buy
170,066
+891
+0.5% +$205K 1.34% 20
2020
Q3
$43M Sell
169,175
-547
-0.3% -$136K 1.67% 11
2020
Q2
$40M Buy
169,722
+1,020
+0.6% +$233K 1.64% 9
2020
Q1
$34.2M Sell
168,702
-3,770
-2% -$823K 1.59% 12
2019
Q4
$41.6M Sell
172,472
-888
-0.5% -$196K 1.52% 10
2019
Q3
$33.5M Buy
173,360
+1,567
+0.9% +$301K 1.28% 19
2019
Q2
$31.7M Buy
171,793
+3,464
+2% +$620K 1.26% 19
2019
Q1
$32M Buy
168,329
+1,663
+1% +$318K 1.35% 16
2018
Q4
$32.4M Sell
166,666
-1,922
-1% -$375K 1.51% 14
2018
Q3
$34.9M Sell
168,588
-277
-0.2% -$54.6K 1.47% 13
2018
Q2
$31.2M Sell
168,865
-4,183
-2% -$740K 1.45% 15
2018
Q1
$29.5M Buy
173,048
+1,599
+0.9% +$294K 1.4% 17
2017
Q4
$29.8M Buy
171,449
+2,445
+1% +$433K 1.38% 16
2017
Q3
$31.5M Sell
169,004
-1,641
-1% -$291K 1.55% 11
2017
Q2
$29.4M Buy
170,645
+501
+0.3% +$81.5K 1.48% 13
2017
Q1
$27.9M Sell
170,144
-1,164
-0.7% -$193K 1.45% 13
2016
Q4
$25M Buy
171,308
+2,995
+2% +$451K 1.34% 21
2016
Q3
$28.1M Sell
168,313
-3,516
-2% -$595K 1.53% 11
2016
Q2
$26.1M Buy
171,829
+104
+0.1% +$16.2K 1.44% 14
2016
Q1
$25.7M Buy
171,725
+2,020
+1% +$300K 1.47% 13
2015
Q4
$27.5M Buy
169,705
+425
+0.3% +$66.8K 1.66% 8
2015
Q3
$23.4M Buy
169,280
+175
+0.1% +$27.6K 1.48% 11
2015
Q2
$26M Sell
169,105
-635
-0.4% -$102K 1.54% 10
2015
Q1
$27.1M Buy
169,740
+897
+0.5% +$141K 1.61% 6
2014
Q4
$26.9M Sell
168,843
-1,335
-0.8% -$208K 1.55% 7
2014
Q3
$23.9M Buy
170,178
+100
+0.1% +$13.1K 1.46% 13
2014
Q2
$20.1M Buy
170,078
+4,884
+3% +$565K 1.2% 34
2014
Q1
$20.4M Sell
165,194
-411
-0.2% -$49.8K 1.27% 34
2013
Q4
$18.9M Sell
165,605
-768
-0.5% -$87.4K 1.22% 38
2013
Q3
$18.6M Sell
166,373
-8,515
-5% -$923K 1.29% 32
2013
Q2
$17.3M Buy
+174,888
New +$18.1M 1.22% 37

Other funds holding AMGN

Vaughan David Investments's AMGN Position: Q2 2026 in Review

Vaughan David Investments reduced its Amgen (AMGN) stake by 2.5% in Q2 2026, selling an estimated $428K and leaving 49,416 shares worth $17.9M. The position accounts for 0.36% of the portfolio, ranked #89.

Vaughan David Investments first reported a position in AMGN in Q2 2013 and has held it in 53 quarters since. The position peaked at $56.6M in Q3 2024. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Vaughan David Investments held 49,416 shares of Amgen worth $17.9M as of Q2 2026.
  • Vaughan David Investments sold 1,250 Amgen shares in Q2 2026, an estimated $428K.
  • Amgen made up 0.36% of Vaughan David Investments's portfolio in Q2 2026, its #89 holding.
  • Vaughan David Investments first reported a position in Amgen in Q2 2013 and has held it in 53 quarters since.
  • Vaughan David Investments's Amgen position peaked at $56.6M in Q3 2024.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Vaughan David Investments's 13F filing for Q2 2026, filed 11 Aug 2026.